SEI Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,369
Closed -$1.96M 2553
2021
Q1
$1.96M Hold
1,369
﹤0.01% 1462
2020
Q4
$1.96M Buy
1,369
+652
+91% +$695K 0.01% 1404
2020
Q3
$490K Sell
717
-976
-58% -$710K ﹤0.01% 1894
2020
Q2
$1.17M Buy
+1,693
New +$978K ﹤0.01% 1494
2020
Q1
Sell
-1,077
Closed -$677K 2356
2019
Q4
$677K Sell
1,077
-567
-34% -$277K ﹤0.01% 1806
2019
Q3
$551K Buy
+1,644
New +$527K ﹤0.01% 1833

Other funds holding CDLX

SEI Investments's CDLX Position: Q2 2021 in Review

SEI Investments sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 1,369 shares — an estimated $1.96M sold.

SEI Investments first reported a position in CDLX in Q3 2019 and held it in 6 quarters. The position peaked at $1.96M in Q1 2021. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • SEI Investments reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
  • SEI Investments sold 1,369 Cardlytics shares in Q2 2021, an estimated $1.96M.
  • SEI Investments first reported a position in Cardlytics in Q3 2019 and held it in 6 quarters.
  • SEI Investments's Cardlytics position peaked at $1.96M in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on SEI Investments's 13F filing for Q2 2021, filed 6 Aug 2021.